Treatment
Comparator clinical trials
We’re tracking 1,699 recruiting studies that include Comparator, each written for real people, not researchers, below.
Recruiting studies
- NCT06608199RecruitingPhase 3
Pneumonia vaccine study for healthy infants
This study tests a new pneumonia vaccine (PCV13) in healthy infants to see if it works as well as a current vaccine. It compares the immune response and safety of the two vaccines.
Denpasar, BaliAges 1 month–2 months - NCT07275827RecruitingPhase 3
Testing 3 treatments for H. pylori infection
This study compares two different acid-reducing medications, given with or without zinc, to see which is safer and works best for treating H. pylori. All treatments are combined with two antibiotics.
Shibīn al KawmAges 19 years+ - NCT07269483Recruiting
Sleep study comparing home diagnostic devices for suspected sleep apnoea
This study tests a wearable device (Sunrise) against two current devices (oximetry and WatchPAT) to find better ways to diagnose obstructive sleep apnoea at home. If you have symptoms of sleep apnoea, you may be able to participate.
Bristol, South WestAges 18 years+ - NCT07278466Recruiting
Comparing app support strategies for depression and anxiety
This study compares different ways of supporting people who use a mental health app for depression or anxiety. It aims to find which type of support helps people feel better and stick with the app.
Madison, WisconsinAges 18–65 - NCT07275710Recruiting
Alprazolam for tooth pain after root canal
This trial tests if adding alprazolam (a mild anti-anxiety medicine) to standard painkillers can better manage pain after a root canal. It aims to find a more effective way to control post-procedure discomfort.
Rawalpindi, Punjab ProvinceAges 18–60 - NCT07269873RecruitingPhase 1
Testing a new implant for opioid use disorder
This study tests a new implant (BICX104) with or without bupropion to see how safe it is and how it works in the body, compared to an existing treatment (Vivitrol). If you are healthy and not using opioids, you may be eligible to help researchers understand if this implant could be a new option for treatment.
Miami, FloridaAges 18–65 - NCT07276087Recruiting
Physical and Mental Health in Takayasu Arteritis and Behçet's Disease
This study compares physical and mental health in people with Takayasu arteritis or Behçet's disease to healthy volunteers. It aims to better understand how these conditions affect day-to-day life and well-being.
Denizli, DenizliAges 18 years+ - NCT07273565Enrolling by invitation
Can microwave images help in follow-up breast imaging?
This study tests a new, non-invasive microwave imaging device to see if it can provide helpful information for women who need extra breast imaging after a mammogram or ultrasound. The goal is to compare the microwave images with standard clinical information to improve future breast cancer screening.
CalgaryAges 18–74 - NCT07272343RecruitingPhase 4
Semaglutide vs. diet changes for new type 2 diabetes
This study compares a weekly injection called semaglutide with a calorie-restricted diet to see which helps control blood sugar better. If you have just been diagnosed with type 2 diabetes and have overweight, this trial might help you choose a treatment path.
Jiangxi, NanchangAges 18–75 - NCT06892028Recruiting
EEG-guided brain stimulation for PTSD in veterans and first responders
This study tests if personalized brain stimulation guided by your brain waves (EEG) can reduce PTSD symptoms. It's for veterans and first responders who have had PTSD for at least 6 months.
Dayton, OhioAges 22–65 - NCT05282108Recruiting
Generic imatinib vs Glivec for newly diagnosed CML
This trial studies whether a generic version of imatinib (Carcemia®) works as well and is as safe as Glivec® in real-life care for people newly diagnosed with chronic phase chronic myeloid leukemia (CML). It may help confirm that the generic option is effective for controlling the disease.
CairoAges 18 years+ - NCT06641713Recruiting
Comparing two liver cancer treatments for large tumors
This trial compares two treatments for people with large liver tumors. One is a liver artery chemotherapy infusion and the other is a chemo-embolization procedure. The study will see which approach works better.
Beijing, Beijing MunicipalityAges 18–75 - NCT06762626Recruiting
Comparing two methods of timing a frozen embryo transfer
This trial compares a new method to time a frozen embryo transfer (using a test called ERA) with the standard method. The goal is to find the best time to transfer a high-quality embryo in women who have had multiple failed IVF attempts (recurrent implantation failure).
Hong KongAges 18–40 - NCT06890000Recruiting
Scapular exercises for shoulder pain relief
This trial tests if special exercises for the shoulder blade (scapula) can reduce shoulder pain better than standard exercises. It is for people with shoulder pain that has lasted at least one month and who have a shoulder blade that moves incorrectly.
AnkaraAges 18 years+ - NCT06888258Recruiting
Comparing two nerve blocks for pain after breast cancer surgery
This study compares two types of nerve blocks for pain relief after breast cancer surgery. It will help determine which block works better to reduce pain and the need for strong pain medicines after a mastectomy.
CairoAges 18–60 - NCT07265674RecruitingPhase 3
Study of nanvuranlat for advanced bile duct cancer
This study tests a new drug called nanvuranlat for people with advanced bile duct cancer that has gotten worse after platinum-based chemotherapy. It compares nanvuranlat with the doctor's choice of standard treatments to see which works better.
Duarte, CaliforniaAges 18 years+ - NCT07260110Recruiting
Study of teplizumab vs. no treatment in stage 2 type 1 diabetes
This study watches people with stage 2 type 1 diabetes who either get teplizumab or not, to compare their real-world experiences. It helps researchers learn how the drug affects daily life.
San Francisco, CaliforniaAges 8 years+ - NCT07262567RecruitingPhase 3
New drug vs chemo for KRAS G12D pancreatic cancer
This study tests a new targeted drug, GFH375, against standard chemotherapy for people with advanced pancreatic cancer that has a specific genetic change called KRAS G12D. The goal is to see if the new drug works better and has fewer side effects.
Beijing, Beijing MunicipalityAges 18–80 - NCT07263984Recruiting
Comparing ultrasound and MRI for uterine septum diagnosis
This study compares advanced ultrasound techniques (3D TVUS and 3D GIS) with MRI to see which is better at diagnosing a uterine septum—a wall-like tissue inside the uterus that can affect fertility or cause miscarriage. If you are a woman aged 18–45 with a possible septum found on a routine ultrasound, you may be eligible.
GhentAges 18–45 - NCT07264075RecruitingPhase 3
Ivonescimab with or without ligufalimab vs pembrolizumab for head and neck cancer
This trial tests a new immunotherapy combination (ivonescimab alone or with ligufalimab) against the standard immunotherapy pembrolizumab (Keytruda) for people with head and neck cancer that has come back or spread. It may be an option if you have not had any prior immunotherapy and your tumor is PD-L1 positive.
Le HavreAges 18–80 - NCT07266662Recruiting
Sensory aids and brain stimulation for stroke recovery
This study tests if adding sensory aids or brain stimulation can improve arm and hand movement for people who had a stroke more than 6 months ago. It may help if you have some movement but not full use of your arm.
Lahore, Punjab ProvinceAges 45–56 - NCT07269093Recruiting
Creams for preventing raised scars: chitosan, silicone, or olive oil
This trial compares three creams—chitosan (from shrimp shells), silicone gel, and olive oil—to see which best prevents raised scars after surgery or injury. You may be able to join if you have a fresh scar that healed within the last two weeks.
Kota Bharu, KelantanAges 18–65 - NCT07264309Recruiting
Pain relief options for women in early labor
This trial compares two pain relief methods during the first stage of labor: a combination of tramadol and paracetamol given through an IV, versus pethidine given as a shot. The goal is to see which works better and has fewer side effects.
AfulaAges Any age - NCT07263386RecruitingPhase 2
Immunotherapy plus chemo for PD-L1-positive stomach cancer
This trial tests whether adding the immunotherapy drug sintilimab to standard chemotherapy (SOX) after surgery helps prevent stomach cancer from returning. It’s for people whose tumors have a protein called PD-L1 and who had cancer in at least 7 lymph nodes.
Nanjing, JiangsuAges 18–75
Common questions
- Are there clinical trials studying Comparator?
- Yes. Clin2 currently lists 1,699 recruiting studies that include Comparator, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Comparator trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Comparator an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Comparator or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.